Articles on antithrombotics from NPS RADARArticles on antithrombotics from NPS RADAR

Title Content Type Date Description
Apixaban (Eliquis) for preventing venous thromboembolism after knee or hip replacement surgery Professional publication - NPS RADAR - Brief item 2012-01-16 00:00:00 From 1 January 2012, apixaban (Eliquis) can be prescribed on the Pharmaceutical Benefits Scheme (PBS) for preventing venous thromboembolism (VTE) in people undergoing total knee or total hip replacement surgery.
Dabigatran (Pradaxa) safety update: assess and monitor kidney function Professional publication - NPS RADAR - Brief item 2011-12-01 00:00:00 The Therapeutic Goods Administration published a Safety Advisory on 3 November 2011 regarding the risk of bleeding in people using dabigatran.
Dabigatran (Pradaxa) for stroke prevention in patients with non-valvular atrial fibrillation Professional publication - NPS RADAR - Review 2011-08-01 00:00:00 Dabigatran is an oral direct thrombin inhibitor. It is approved for the prevention of stroke in patients with non-valvular atrial fibrillation, and the prevention of venous thromboembolism after hip or knee replacement surgery.
Dabigatran (Pradaxa) for preventing venous thromboembolism after hip or knee replacement surgery Professional publication - NPS RADAR - Review 2010-04-01 00:00:00 Dabigatran is an oral direct thrombin inhibitor anticoagulant. It is approved for short-term use to prevent deep vein thrombosis and pulmonary embolism after total hip or total knee replacement surgery.
Prasugrel (Effient) for acute coronary syndrome in people undergoing percutaneous coronary intervention Professional publication - NPS RADAR - Review 2009-12-01 00:00:00 Prasugrel is an alternative to clopidogrel for acute coronary syndrome managed by percutaneous coronary intervention in combination with aspirin. It reduces the risk of atherothrombotic events more than clopidogrel, but at the expense of more bleeding.
Clopidogrel (Iscover, Plavix) PBS listing extended to cardiac stent insertion Professional publication - NPS RADAR - Brief item 2009-08-01 00:00:00 Clopidogrel, in combination with aspirin, can be prescribed on the PBS following coronary artery stent insertion.
Rivaroxaban (Xarelto) for preventing venous thromboembolism after hip or knee replacement surgery Professional publication - NPS RADAR - Review 2009-08-01 00:00:00 Rivaroxaban is an oral factor Xa–inhibitor anticoagulant. It is approved for short-term use to prevent deep vein thrombosis and pulmonary embolism after elective total hip or total knee replacement surgery.
Clopidogrel (Iscover, Plavix) PBS listing extended to include acute coronary syndrome (ACS) in combination with aspirin Professional publication - NPS RADAR - Brief item 2009-03-03 00:00:00 Clopidogrel (Iscover, Plavix) and aspirin can now be prescribed in combination for acute coronary syndrome (ACS). The extended listing includes the treatment of myocardial infarction (MI) or unstable angina to prevent atherothrombotic events.

NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.

RSS FeedRSS feed

Date published: 2009-10-28 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.